What is the market doing?
What the tape says about KYMR
Kymera Therapeutics, Inc. is +207% over the past year while the S&P 500 is +23%: 184 points ahead of the market.
+207%
1-year return · S&P 500 +23%
- vs 200-day average
- +49%
vs 200-day average · a clear uptrend
- RSI (14)
- 76
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −1.5%
Below its 52-week high
Details›
- Last close2026-08-26
- $125.37
- 1 monthS&P 500 +3.7%
- +14%
- 1 yearS&P 500 +23%
- +207%
- 5 yearsS&P 500 +87%
- +110%
- vs 50-day average$102.98
- +22%
- 52-week high
- $127.24
- 52-week low
- $37.68
- Annualised volatility
- 70%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$176M
| Year | Return |
|---|---|
| 2026 (year to date) | +61% |
| 2025 | +93% |
| 2024 | +58% |
| 2023 | +2.0% |
| 2022 | −61% |
| 2021 | +2.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | +6.1% |
| Feb | 6 | 2 of 6 | −1.5% |
| Mar | 6 | 1 of 6 | −7.6% |
| Apr | 6 | 3 of 6 | +0.65% |
| May | 6 | 2 of 6 | −12% |
| Jun | 6 | 4 of 6 | +17% |
| Jul | 6 | 4 of 6 | +13% |
| Aug | 6 | 4 of 6 | +6.0% |
| Sep | 6 | 2 of 6 | −3.2% |
| Oct | 6 | 4 of 6 | +7.0% |
| Nov | 6 | 4 of 6 | +18% |
| Dec | 6 | 4 of 6 | +9.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.